17 November 2026
CML Microsystems Plc
("CML", the "Company" or the "Group")
HALF YEAR RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2026
Strong revenue and earnings growth with trading ahead of Board expectations
CML Microsystems Plc (AIM: CML), which develops mixed-signal, RF and microwave semiconductors for global communications markets, is pleased to announce its half year results for the six months ended 30 September 2026 (“H1 FY27”).
|
|
H1 FY27 |
|
H1 FY26 |
|
Revenue |
£12.32m |
|
£9.18m |
|
Adjusted EBITDA1 |
£2.12m |
|
£1.20m |
|
Operating profit, before exceptional items |
£0.19m |
|
£(0.98)m |
|
Pre-tax profit/(loss), before exceptional items |
£0.26m |
|
£(0.89)m |
|
Basic earnings/(loss) per share, before exceptional items3 |
1.03p |
|
(6.10)p |
|
Net cash2 |
£10.95m |
|
£10.68m |
|
Operating profit, reported |
£0.19m |
|
£2.43m4 |
|
Pre-tax profit, reported |
£0.26m |
|
£2.52m4 |
|
Net assets per share |
307.20p |
|
309.80p |
|
Dividend |
5.00p |
|
5.00p |
Operational Highlights
Financial Highlights
Chris Gurry, Chief Executive Officer of CML Microsystems, commented:
“We are pleased with the strong progress delivered in the first half, with trading ahead of our expectations and growth across all regions. We are particularly encouraged by the strength of order intake and our expanding opportunity pipeline, which are providing greater medium-term revenue visibility and reinforcing our confidence in the Group’s future growth prospects.
“The progress being made across our target market verticals demonstrates that the investments we have made in our product portfolio, operations and routes to market are delivering tangible results. With this momentum continuing and a growing order backlog, we are confident in delivering further progress in the second half and beyond.”
|
CML Microsystems Plc
Chris Gurry, Chief Executive Officer |
Tel: +44(0)1621 875 500 |
|
Shore Capital Toby Gibbs James Thomas Lucy Bowden Fiona Conroy (Corporate Broking) |
Tel: +44(0)20 7408 4090 |
|
Alma Strategic Communications Josh Royston Andy Bryant Anna Sutton |
Tel: +44 (0)20 3405 0212
|
About CML Microsystems Plc
CML develops mixed-signal, RF and microwave semiconductors for global communications markets. The Group utilises a combination of outsourced manufacturing and in-house testing with trading operations in the UK, Asia and USA. CML targets sub-segments within Communication markets with strong growth profiles and high barriers to entry. It has secured a diverse, blue chip customer base, including some of the world's leading commercial and industrial product manufacturers.
Growth in its end markets is being driven by factors such as the appetite for data to be transmitted faster and more securely, the upgrading of telecoms infrastructure around the world and the growing prevalence of private commercial wireless networks for voice and/or data communications linked to the industrial internet of things (IIoT).
The Group is cash-generative, has no debt and is dividend paying.
Chief Executive’s review
Overview
The Group entered FY27 with encouraging momentum and we are pleased to report that this impetus has continued, with trading for the first six-months of the financial year ahead of the Board’s expectations.
Revenues increased by 34% against the equivalent prior-year period, with strong gains across all our regions: EMEA sales rose 89%, the Americas were up 57%, and Asia grew by 11%.
Order intake has been particularly strong, with a book‑to‑bill ratio well above one, reflecting sustained multi‑year commitments from key customers. As a result, medium-term revenue visibility has markedly improved, with an order backlog now extending beyond the next two years, while the steadily expanding opportunity pipeline has a total lifetime value, measured on a prudent basis, exceeding £190 million.
Overall, the performance delivered in the first half is clear evidence that the business is gaining momentum and making progress against our strategy to grow and diversify future revenue streams, further validating the multi-year corporate and operational transformation undertaken.
Markets & Products
The Company is continuing to scale by broadening its business base. We began the year having refined our target market verticals, and focus application areas, following extensive analysis of customer and market interactions over an 18-month timeframe. Turning to these market verticals, progress against the prior full year period has been tangible;
Defence & Aerospace
Defence & Aerospace delivered strong growth, supported by successful engineering work in the prior year to restore supply for several key products affected by geopolitical tensions between the US and China. H1 revenues within this sector are already at 75% of those achieved for the 12-month period to March 2026.
Network Infrastructure
Network Infrastructure sales grew as our class-leading semiconductor products gained acceptance and began to penetrate a broader share of the expanding customer base’s product portfolio. Revenues for the first half are at 81% of the prior full year.
Industrial IoT
Industrial IoT sector sales rebounded in H1 and are already at 60% of the prior year number, driven by demand for “Smart Everything” and mission-critical machine-to-machine connectivity. Alongside the Group’s standard catalogue IC product line, the development of a high-performance RF IC for a major GNSS receiver manufacturer and its planned multi-year supply, is progressing to plan. The contract is valued at over $30m, with design of the chip tracking to plan and production availability targeted for calendar year 2028.
Professional and Industrial Communications
Sales into professional and industrial communications applications grew well, ending the first half at a healthy 57% of the prior full year finishing point, contributing to 50% of overall Group revenues. The sector continues to have good growth prospects, with several more recent product initiatives still building towards meaningful revenue generation.
Importantly, across the whole business the contribution from new products, classified as those introduced to market by CML over the last five years, represented 24% of Group revenues, demonstrating good returns from our more recent R&D investments. The pace of progress with our newer products remains consistent with the established time-lag from market introduction of a new standard product, through to multiple design-win successes and ultimately meaningful revenue generation. With further momentum expected from newer products over the coming periods, we see this as a strong vindication of our targeted and consistent approach to R&D.
Several new design-wins and first production orders were recorded across all four market verticals, addressing a variety of end-applications including 5G backhaul, digital mobile radio, military voice, data and video communications, military radar and asset tracking.
Operations
We continue to focus on third-party routes to market and sales channels that act as an extension of the CML direct sales team. New appointments were made in the Americas, with other regions being actively reviewed in order to maximise access to and strengthen support for what is now a wider target customer base.
Marketing activities included participation at four dedicated international trade show events: IMS (Boston), EuMW (London), IBC (Amsterdam) and Microelectronics UK (London) with new product launches and real-time audience-focussed technical demonstrations.
One of CML’s strengths is the ability to 100% test our semiconductor products in-house at three locations across the world within the UK, US & Asia. During the prior year investments were made to modernise capabilities and improve final test throughput. The combination of capital equipment investment and internal engineering expertise has delivered meaningful efficiencies. Leadership was strengthened towards the end of the period to drive additional global manufacturing, procurement and operational excellence initiatives.
Industry-wide demand continues to drive longer IC packaging lead times, with the Group taking appropriate steps to minimise the impact this may have on our customers. During these times, strong supplier relationships are fundamental to success, with the Group’s multi-decade semiconductor industry heritage serving as a key benefit.
CFO
The Board was pleased to recently announce the appointment of Adrian Keane as Chief Financial Officer ("CFO") and Executive Director, with effect from 1 February 2027. Adrian brings a strong background across international engineering, electronics and manufacturing businesses, including over 25 years as CFO. We look forward to him joining in the coming months.
Outlook
The Group’s enlarged product portfolio, growing opportunity pipeline and end market focus, underpin a strong platform for sustainable growth. The Group is on track to deliver continued improvements in trading in the second half, both sequentially and against the prior year, which is likely to result in a year end outcome ahead of current market expectations. The improvement in medium term visibility, underpinned by our growing order backlog, gives us increased confidence as we look beyond FY27.
We are well positioned to capitalise on the major structural investments being made in global communications markets, supported by strong technical expertise, operational excellence and compelling semiconductor solutions.
The Board is confident its strategy will deliver long-term value for shareholders and would like to thank our customers, partners, and employees for their continued support and commitment.
Financial summary
Revenue & Margin
Revenues for the first six-months of the financial year were £12.32m (H1 FY26: £9.18m), a 34% increase against the prior year first-half, with growth broadly spread across geographic regions and market verticals.
The overall product mix, combined with a full six-months of contractual NRE income, delivered a gross margin of 64%. This is a three-percentage point reduction from that reported for the corresponding period (H1 FY26: 67%), but a 1% improvement against FY26 as a whole. As a result, gross profit increased by 29% to £7.94m (H1 FY26 £6.16m).
Distribution & Administration
Distribution and administration expenses rose to £7.97m (H1 FY26: £7.14m) with the main difference being the treatment of R&D. Across this reporting period, a higher proportion of the R&D budget was allocated to engineering research activities that are expected to unlock technical and commercial advantages for the Group in future years. These activities were expensed as incurred.
The cash spend on R&D amounted to £2.41m, with £1.29m being expensed and the balance capitalised. For H1 FY26, cash spend was £2.75m with £0.51m expensed, the net effect being that an additional £0.78m of R&D related expense was incurred in H1 against the comparable period.
Looking beyond the differences in R&D expense, underlying operating costs continue to be managed tightly, growing 6% in the first half, significantly below the 34% growth in revenue, whilst still allowing for further investment in sales capability.
Other Operating Income
The Group receives R&D expenditure credits (RDEC) on qualifying expenses, which is allocated to ‘other operating income’ within the profit and loss account and is taxable. A figure of £0.17m has been recognised for the period (H1 FY26: £0.13m). Along with an additional amount of £0.14m received from a one-off precious metal reclamation, a total other operating income figure of £0.35m was posted (H1 FY26: £0.15m).
Profit & Taxation
A pre-exceptional £0.19m profit from operations was recorded compared to a prior year pre-exceptional operating loss of £0.98m. After factoring in net finance and other income, a profit before tax of £0.26m was achieved (H1 FY26: pre-exceptional loss before tax £0.89m).
Adjusted EBITDA grew by 77% to £2.12m (H1 FY26: £1.20m) as revenue growth comfortably exceeded cost inflation and the increase in expensed R&D. Adjusted EBITDA margins grew by 4.1% percentage points to 17.2% (H1 FY26: 13.1%).
A pre-exceptional tax charge of £0.09m was recorded (H1 FY26: £0.08m), equating to a higher tax rate than expected due to prior year tax adjustments. Basic earnings per share amounted to 1.03p against a prior year loss per share of 6.10p, pre-exceptionals.
Inventories
In recent years, there was a need to keep raw material inventory levels relatively elevated as we worked through several market-wide issues, including semiconductor process transfers and geopolitical uncertainties. Across the previous two reporting periods, those levels had fallen and the expectation was for that to continue. The record order-intake for H1, alongside expansion into key vertical markets that often require extended multi-year support, have necessitated a return to ensuring security of supply. At 30 September 2026, inventories were valued at £5.41m (31 March 2026: £4.76m).
Cash
The balance sheet remains strong, with cash and cash equivalents totalling £10.95m at 30 September 2026 (31 March 2026: £12.80m). Cash outflows included investment in research and development (£2.41m), a final dividend payment (£1.0m) and a deferred payment of consideration (£0.25m).
Dividend
The Board is declaring an interim dividend of 5p per ordinary share (H1 FY26: 5.0p), payable on 11 December 2026 to shareholders on the register on 27 November 2026.
Chris Gurry
Chief Executive Officer
17 November 2026
Condensed consolidated income statement
for the six months ended 30 September 2026
|
|
|
|
|
|
|
|
||||||||||
|
|
Unaudited 6 months ended 30/09/26 |
Unaudited 6 months ended 30/09/25 |
Audited year ended 31/03/26 |
|||||||||||||
|
|
Before exceptional items |
Exceptional items |
Total |
Before exceptional items |
Exceptional items |
Total |
Before exceptional Items |
Exceptional items |
Total |
|||||||
|
|
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
|||||||
|
Continuing operations |
|
|
|
|
|
|
|
|
|
|||||||
|
Revenue (note 3) |
12,324 |
– |
12,324 |
9,178 |
– |
9,178 |
20,449 |
– |
20,449 |
|||||||
|
Cost of sales |
(4,389) |
– |
(4,389) |
(3,020) |
– |
(3,020) |
(7,560) |
– |
(7,560) |
|||||||
|
Gross profit |
7,935 |
– |
7,935 |
6,158 |
– |
6,158 |
12,889 |
– |
12,889 |
|||||||
|
Distribution and administration costs |
(7,969) |
– |
(7,969) |
(7,134) |
– |
(7,134) |
(15,279) |
– |
(15,279) |
|||||||
|
Share-based payments |
(126) |
– |
(126) |
(145) |
– |
(145) |
(288) |
– |
(288) |
|||||||
|
|
(160) |
– |
(160) |
(1,121) |
– |
(1,121) |
(2,678) |
– |
(2,678) |
|||||||
|
Other operating income |
345 |
– |
345 |
145 |
– |
145 |
747 |
– |
747 |
|||||||
|
Other gains/(losses) (note 5) |
– |
– |
– |
– |
3,406 |
3,406 |
– |
1,690 |
1,690 |
|||||||
|
Profit /(loss) from operations |
185 |
– |
185 |
(976) |
3,406 |
2,430 |
(1,931) |
1,690 |
(241) |
|||||||
|
Other income |
4 |
– |
4 |
14 |
– |
14 |
32 |
– |
32 |
|||||||
|
Finance income |
109 |
– |
109 |
122 |
– |
122 |
226 |
– |
226 |
|||||||
|
Finance expense |
(39) |
– |
(39) |
(50) |
– |
(50) |
(91) |
– |
(91) |
|||||||
|
Profit /(loss) before taxation |
259 |
– |
259 |
(890) |
3,406 |
2,516 |
(1,764) |
1,690 |
(74) |
|||||||
|
Income tax (charge)/credit (note 6) |
(86) |
– |
(86) |
(82) |
(591) |
(673) |
1,203 |
(1,183) |
20 |
|||||||
|
Profit /(loss) after taxation for period attributable to equity owners of the parent |
173 |
– |
173 |
(972) |
2,815 |
1,843 |
(561) |
507 |
(54) |
|||||||
All financial information presented relates to continuing activities.
Earnings per share from total operations attributable to the ordinary equity holders of the Company:
|
Basic earnings /(loss) per share |
|
|
1.03p |
|
|
11.57p |
|
|
(0.33)p |
|
Diluted earnings /(loss) per share |
|
|
1.02p |
|
|
11.54p |
|
|
(0.33)p |
The following measure is considered an alternative performance measure, not a generally accepted accounting principle. This ratio is useful to ensure that the level of borrowings in the business can be supported by the cash flow in the business. For definition and reconciliation see note 9.
|
Adjusted EBITDA (note 9) |
|
|
2,121 |
|
|
1,203 |
|
|
2,343 |
Condensed consolidated statement of total comprehensive income
for the six months ended 30 September 2026
|
|
Unaudited 6 months ended |
Unaudited 6 months ended |
Audited Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Profit /(loss) for the period |
173 |
1,843 |
(54) |
|
Other comprehensive income /(expense): |
|
|
|
|
Items that will not be reclassified subsequently to profit or loss: |
|
|
|
|
Re-measurement of defined benefit obligation |
– |
– |
639 |
|
Deferred tax on actuarial gain |
– |
– |
(160) |
|
Revaluation surplus - gross |
– |
– |
1,882 |
|
Deferred tax on revaluation surplus |
– |
– |
(470) |
|
Items reclassified subsequently to profit or loss upon derecognition: |
|
|
|
|
Foreign exchange differences |
138 |
(722) |
(56) |
|
Other comprehensive income /(loss) for the period net of taxation attributable to the equity holders of the parent |
138 |
(722) |
1,835 |
|
Total comprehensive income for the period attributable to the equity holders of the parent |
311 |
1,121 |
1,781 |
Condensed consolidated statement of financial position
as at 30 September 2026
|
|
Unaudited |
Unaudited |
Audited |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Assets |
|
|
|
|
Non-current assets |
|
|
|
|
Goodwill |
12,691 |
12,200 |
12,618 |
|
Other intangible assets |
2,092 |
2,408 |
2,272 |
|
Development costs |
14,558 |
17,911 |
14,531 |
|
Property, plant and equipment |
7,494 |
5,816 |
7,631 |
|
Right-of-use assets |
1,557 |
1,824 |
1,783 |
|
Investment properties |
1,975 |
– |
1,975 |
|
Deferred tax assets |
1,284 |
1,039 |
1,265 |
|
|
41,651 |
41,198 |
42,075 |
|
Current assets |
|
|
|
|
Property, plant and equipment – held for sale |
– |
529 |
– |
|
Investment properties – held for sale |
– |
1,975 |
– |
|
Inventories |
5,408 |
5,263 |
4,761 |
|
Trade receivables and prepayments |
3,269 |
4,429 |
3,471 |
|
Current tax assets |
504 |
103 |
347 |
|
Cash and cash equivalents (note 8) |
5,366 |
8,780 |
6,255 |
|
Short-term cash deposits (note 8) |
5,582 |
1,901 |
6,545 |
|
|
20,129 |
22,980 |
21,379 |
|
Total assets |
61,780 |
64,178 |
63,454 |
|
Liabilities |
|
|
|
|
Current liabilities |
|
|
|
|
Trade and other payables |
3,608 |
6,286 |
4,584 |
|
Provisions |
343 |
192 |
490 |
|
Lease liabilities |
452 |
370 |
408 |
|
Current tax liabilities |
144 |
59 |
101 |
|
|
4,547 |
6,907 |
5,583 |
|
Non-current liabilities |
|
|
|
|
Deferred tax liabilities |
4,150 |
4,771 |
4,260 |
|
Trade and other payables |
– |
447 |
– |
|
Lease liabilities |
1,299 |
1,623 |
1,549 |
|
Retirement benefit obligation |
608 |
1,076 |
608 |
|
|
6,057 |
7,917 |
6,417 |
|
Total liabilities |
10,604 |
14,824 |
12,000 |
|
Net assets |
51,176 |
49,354 |
51,454 |
|
Capital and reserves attributable to equity owners of the parent |
|
|
|
|
Share capital |
853 |
825 |
853 |
|
Share premium |
2,199 |
2,230 |
2,199 |
|
Capital redemption reserve |
8,372 |
8,372 |
8,372 |
|
Other reserve |
4,697 |
2,929 |
4,633 |
|
Revaluation surplus reserve |
1,412 |
– |
1,412 |
|
Treasury shares – own share reserve |
(1,493) |
(2,101) |
(1,682) |
|
Share-based payments reserve |
1,030 |
1,002 |
921 |
|
Foreign exchange reserve |
(530) |
(1,334) |
(668) |
|
Retained earnings |
34,636 |
37,431 |
35,414 |
|
Total shareholders’ equity |
51,176 |
49,354 |
51,454 |
Condensed consolidated cash flow statement
for the six months ended 30 September 2026
|
|
Unaudited |
Unaudited |
Audited |
|
|
6 months ended |
6 months ended |
Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Operating activities |
|
|
|
|
Profit /(loss) for the period before taxation |
259 |
2,516 |
(74) |
|
Adjustments for: |
|
|
|
|
Foreign exchange movement |
102 |
74 |
160 |
|
Depreciation – on property, plant and equipment |
311 |
322 |
581 |
|
Depreciation – on right-of-use assets |
214 |
217 |
435 |
|
Amortisation of development costs |
1,098 |
1,263 |
2,529 |
|
Impairment of development costs |
– |
– |
4,186 |
|
Amortisation of other intangibles |
183 |
218 |
409 |
|
Loss /(Profit) on disposal of fixed assets |
1 |
(3,406) |
(5,876) |
|
Movement in non-cash items (retirement benefit obligation) |
90 |
90 |
171 |
|
Share-based payments |
126 |
145 |
288 |
|
Finance income |
(109) |
(122) |
(226) |
|
Finance expense |
39 |
50 |
91 |
|
Movement in working capital |
(1,614) |
(25) |
3,294 |
|
Cash flows from operating activities |
700 |
1,342 |
5,968 |
|
Income tax paid |
(40) |
(652) |
(1,375) |
|
Net cash inflow from operating activities |
660 |
690 |
4,593 |
|
Investing activities |
|
|
|
|
Purchase of property, plant and equipment |
(179) |
(463) |
(651) |
|
Investment in development costs |
(1,117) |
(2,244) |
(4,286) |
|
Repayment /(investment) in fixed term deposits (net) |
963 |
235 |
(4,409) |
|
Proceeds from sale of fixed assets |
– |
4,000 |
7,000 |
|
Payment of deferred consideration (business combinations) |
(253) |
– |
(2,067) |
|
Investment in intangibles |
(18) |
(20) |
(31) |
|
Finance income |
109 |
122 |
226 |
|
Net cash (outflow)/inflow investing activities |
(495) |
1,630 |
(4,218) |
|
Financing activities |
|
|
|
|
Lease liability repayments |
(229) |
(226) |
(480) |
|
Issue of ordinary shares (net of expenses) |
189 |
46 |
462 |
|
Dividends paid to shareholders |
(1,000) |
(956) |
(1,786) |
|
Finance expense |
(4) |
(9) |
(10) |
|
Net cash outflow from financing activities |
(1,044) |
(1,145) |
(1,814) |
|
(Decrease)/increase in cash, cash equivalents and short-term cash deposits |
(879) |
1,175 |
(1,439) |
|
Movement in cash and cash equivalents: |
|
|
|
|
At start of period/year |
6,255 |
7,782 |
7,782 |
|
(Decrease)/increase in cash, cash equivalents and short-term cash deposits |
(879) |
1,175 |
(1,439) |
|
Effects of exchange rate changes |
(10) |
(177) |
(88) |
|
At end of period |
5,366 |
8,780 |
6,255 |
Cash flows presented exclude sales taxes. Further cash-related disclosure details are provided in note 8.
Changes in liabilities arising from financing activities relate to lease liabilities only.
Condensed consolidated statement of changes in equity
for the six months ended 30 September 2026
|
|
|
|
Capital |
|
Revaluation |
|
Share- |
Foreign |
|
|
|
|
|
Share |
Share |
redemption |
Other |
surplus |
Treasury |
based |
exchange |
Retained |
|
|
|
|
capital |
premium |
reserve |
reserve |
reserve |
shares |
payments |
reserve |
earnings |
Total |
|
|
Unaudited |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
|
|
At 31 March 2025 |
825 |
2,258 |
8,372 |
2,929 |
– |
(2,175) |
917 |
(612) |
36,492 |
49,006 |
|
|
Profit for period |
|
|
|
|
|
|
|
|
1,843 |
1,843 |
|
|
Other comprehensive income net of taxes |
|
|
|
|
|
|
|
||||
|
Foreign exchange differences |
|
|
|
|
|
|
|
(722) |
|
(722) |
|
|
Total comprehensive income for the period |
– |
– |
– |
– |
– |
– |
– |
(722) |
1,843 |
1,121 |
|
|
|
825 |
2,258 |
8,372 |
2,929 |
– |
(2,175) |
917 |
(1,334) |
38,335 |
50,127 |
|
|
Transactions with owners in their capacity as owners |
|
|
|
|
|
|
|||||
|
Issue of treasury shares |
|
(28) |
|
|
|
74 |
|
|
|
46 |
|
|
Dividends paid |
|
|
|
|
|
|
|
|
(956) |
(956) |
|
|
Total of transactions with owners in their capacity as owners |
– |
(28) |
– |
– |
– |
74 |
– |
– |
(956) |
(910) |
|
|
Share-based payment charge |
|
|
|
|
|
|
145 |
|
|
145 |
|
|
Deferred tax on share-based payments |
|
|
|
|
|
|
|
|
(8) |
(8) |
|
|
Cancellation/transfer of share-based payments |
|
|
|
|
|
|
(60) |
|
60 |
– |
|
|
At 30 September 2025 |
825 |
2,230 |
8,372 |
2,929 |
– |
(2,101) |
1,002 |
(1,334) |
37,431 |
49,354 |
|
|
Loss for period |
|
|
|
|
|
|
|
|
(1,897) |
(1,897) |
|
|
Other comprehensive income net of taxes |
|
|
|
|
|
|
|
||||
|
Foreign exchange differences |
|
|
|
|
|
|
|
666 |
|
666 |
|
|
Re-measurement of defined benefit obligation |
|
|
|
|
|
|
|
|
639 |
639 |
|
|
Deferred tax on actuarial gain |
|
|
|
|
|
|
|
|
(160) |
(160) |
|
|
Revaluation surplus - gross |
|
|
|
|
1,882 |
|
|
|
|
1,882 |
|
|
Deferred tax on revaluation surplus |
|
|
|
|
(470) |
|
|
|
|
(470) |
|
|
Total comprehensive income for the period |
– |
– |
– |
– |
1,412 |
– |
– |
666 |
(1,418) |
660 |
|
|
|
825 |
2,230 |
8,372 |
2,929 |
1,412 |
(2,101) |
1,002 |
(668) |
36,013 |
50,014 |
|
|
Transactions with owners in their capacity as owners |
|
|
|
|
|
||||||
|
Issue of ordinary shares |
28 |
|
|
1,704 |
|
|
|
|
|
1,732 |
|
|
Issue of treasury shares |
|
(31) |
|
|
|
419 |
|
|
|
388 |
|
|
Dividends paid |
|
|
|
|
|
|
|
|
(830) |
(830) |
|
|
Total of transactions with owners in their capacity as owners |
28 |
(31) |
– |
1,704 |
– |
419 |
– |
– |
(830) |
1,290 |
|
|
Share-based payment charge |
|
|
|
|
|
|
143 |
|
|
143 |
|
|
Deferred tax on share-based payments |
|
|
|
|
|
|
|
|
7 |
7 |
|
|
Cancellation/transfer of share-based payments |
|
|
|
|
|
|
(224) |
|
224 |
– |
|
|
At 31 March 2026 |
853 |
2,199 |
8,372 |
4,633 |
1,412 |
(1,682) |
921 |
(668) |
35,414 |
51,454 |
|
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY continued
for the six months ended 30 September 2026
|
|
|
|
Capital |
|
Revaluation |
|
Share- |
Foreign |
|
|
|
|
|
Share |
Share |
redemption |
Other |
surplus |
Treasury |
based |
exchange |
Retained |
|
|
|
|
capital |
premium |
reserve |
reserve |
reserve |
shares |
payments |
reserve |
earnings |
Total |
|
|
Unaudited |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
|
|
At 31 March 2026 |
853 |
2,199 |
8,372 |
4,633 |
1,412 |
(1,682) |
921 |
(668) |
35,414 |
51,454 |
|
|
Profit for period |
|
|
|
|
|
|
|
|
173 |
173 |
|
|
Other comprehensive income net of taxes |
|
|
|
|
|
|
|
||||
|
Foreign exchange differences |
|
|
|
|
|
|
|
138 |
|
138 |
|
|
Total comprehensive income for the period |
– |
– |
– |
– |
– |
– |
– |
138 |
173 |
311 |
|
|
|
853 |
2,199 |
8,372 |
4,633 |
1,412 |
(1,682) |
921 |
(530) |
35,587 |
51,765 |
|
|
Transactions with owners in their capacity as owners |
|
|
|
|
|
|
|||||
|
Issue of treasury shares |
|
|
|
64 |
|
189 |
|
|
|
253 |
|
|
Dividends paid |
|
|
|
|
|
|
|
|
(1,000) |
(1,000) |
|
|
Total of transactions with owners in their capacity as owners |
– |
– |
– |
64 |
– |
189 |
– |
– |
(1,000) |
(747) |
|
|
Share-based payment charge |
|
|
|
|
|
|
126 |
|
|
126 |
|
|
Deferred tax on share-based payments |
|
|
|
|
|
|
|
|
32 |
32 |
|
|
Cancellation/transfer of share-based payments |
|
|
|
|
|
|
(17) |
|
17 |
– |
|
|
At 30 September 2026 |
853 |
2,199 |
8,372 |
4,697 |
1,412 |
(1,493) |
1,030 |
(530) |
34,636 |
51,176 |
|
Notes to the condensed consolidated financial statements
for the six months ended 30 September 2026
1 Basis of preparation and approval of interim statements
The financial information for the six months ended 30 September 2026 and for the six months ended 30 September 2025 is unaudited.
The interim financial statements for the six months to 30 September 2026 do not include all of the information required for full annual financial statements and should be read in conjunction with the consolidated financial statements for the year ended 31 March 2026.
The Financial statements have been prepared on the basis of UK adopted international accounting standards (IFRS’s) that the Directors expect to be applicable as at 31 March 2027.
The accounting policies adopted in the preparation of the interim financial statements are consistent with those set out in the Group’s Annual Report and Financial Statements 2026, which were prepared in accordance with IFRSs.
These interim financial statements do not comprise statutory accounts within the meaning of Section 435 of the Companies Act 2006. Statutory accounts for the year ended 31 March 2026 were approved by the Board on 29 June 2026 and delivered to the Registrar of Companies. The report of the auditor on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 498(2) or Section 498(3) of the Companies Act 2006.
AIM-quoted companies are not required to comply with IAS 34 ‘Interim Financial Reporting’ and accordingly the Company has not applied this standard in preparing this report.
The interim financial statements were approved by the Board of Directors on 17 November 2026.
2 Segmental analysis
Reported segments and their results, in accordance with IFRS 8, are based on internal management reporting information that is regularly reviewed by the Group Managing Director, who is the Chief Operating Decision Maker. The measurement policies the Group uses for segmental reporting under IFRS 8 are the same as those used in its financial statements.
The Group is focused for management purposes on one primary reporting segment, being the semiconductor segment, with similar economic characteristics, risks and returns, and the Directors therefore consider there to be one single segment, being semiconductor components for the communications industry.
Geographical segments (by origin)
|
|
Unaudited |
Unaudited |
Audited |
|
|
6 months ended |
6 months ended |
Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Revenue to third parties |
|
|
|
|
UK |
1,821 |
1,642 |
6,367 |
|
Americas |
4,685 |
2,308 |
4,081 |
|
Far East |
5,818 |
5,228 |
10,001 |
|
Total |
12,324 |
9,178 |
20,449 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
6 months ended |
6 months ended |
Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Total assets |
|
|
|
|
UK |
43,621 |
48,813 |
46,239 |
|
Americas |
5,707 |
4,620 |
5,591 |
|
Far East |
12,452 |
10,745 |
11,624 |
|
Total |
61,780 |
64,178 |
63,454 |
3 Revenue
The geographical classification of business turnover (by destination) is as follows:
|
|
Unaudited |
Unaudited |
Audited |
|
|
6 months ended |
6 months ended |
Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Europe |
3,352 |
1,772 |
3,951 |
|
Far East |
5,817 |
5,227 |
10,759 |
|
Americas |
2,865 |
1,829 |
5,053 |
|
Other |
290 |
350 |
686 |
|
|
12,324 |
9,178 |
20,449 |
The operational classification of business turnover (by market) is as follows:
|
|
Unaudited |
Unaudited |
Audited |
|
|
6 months ended |
6 months ended |
Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Semiconductor |
11,347 |
8,770 |
18,561 |
|
Design and development |
977 |
408 |
1,888 |
|
|
12,324 |
9,178 |
20,449 |
Semiconductor products, goods and services are transferred at a point in time whereas design and development revenue is transferred over the period of the contract on a percentage basis of contract completion, as detailed in the Group’s revenue recognition policy within its published Annual Report.
The Group does not have any contract assets or liabilities at 30 September 2026 (£Nil at 31 March 2026) from semiconductors as it does not fulfil any of its performance obligations in advance of invoicing to its customer. The Group has contract assets of £13,000 as at 30 September 2026 (£265,000 at 31 March 2026) from design and development and contract liabilities of £683,000 as at 30 September 2026 (£Nil at 31 March 2026) from design and development. The Group has contractual balances in the form of trade receivables. See note 20 for disclosure of this in the Annual Report and Accounts for the year ended 31 March 2026.
The Group expects all contractual costs capitalised or any outstanding performance obligations will be completed within the next twelve months.
4 Dividends paid and interim dividend
The Board is declaring an interim dividend of 5p per ordinary share for the half year ended 30 September 2026, payable on 11 December 2026 to shareholders on the Register on 27 November 2026.
A final dividend of 6p per ordinary share was paid on 21 August 2026 and an interim dividend of 5p per ordinary share was paid on 12 December 2025, totalling 11p per ordinary share paid for the year ended 31 March 2026 (2025: 11p per ordinary share paid for the year ended 31 March 2025).
5 Other gains/(losses)
|
|
Unaudited |
Unaudited |
Audited |
|
|
6 months ended |
6 months ended |
Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Profit on sale of fixed assets |
– |
3,406 |
5,876 |
|
Impairment of development costs |
– |
– |
(4,186) |
|
|
– |
3,406 |
1,690 |
During the year ended 31 March 2026, the Group disposed of the excess land at Oval Park for a total consideration of £7,000,000 (plot 1 was sold in July 2025 for £4,000,000 and plot 2 was sold in March 2026 for £3,000,000). An impairment review of the carrying costs of the Group’s development expenditure took place which resulted in the development costs being impaired in the year.
6 Income tax expense/(credit)
|
|
Unaudited |
Unaudited |
Audited |
|
|
|
6 months ended |
6 months ended |
Year ended |
|
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
|
£’000 |
£’000 |
£’000 |
|
|
Current tax |
|
|
|
|
|
UK corporation tax on results of the period/year |
37 |
628 |
1,070 |
|
|
Adjustment in respect of previous years |
11 |
(27) |
89 |
|
|
|
48 |
601 |
1,159 |
|
|
Foreign tax on results of the period/year |
137 |
97 |
192 |
|
|
Total current tax |
185 |
698 |
1,351 |
|
|
Deferred tax |
|
|
|
|
|
Deferred tax – origination and reversal of temporary differences |
|
|
|
|
|
(202) |
2 |
(1,788) |
||
|
Adjustments to deferred tax charge in respect of previous years |
|
|
|
|
|
103 |
(27) |
417 |
||
|
Total deferred tax |
(99) |
(25) |
(1,371) |
|
|
Tax expense/(credit) on profit on ordinary activities |
86 |
673 |
(20) |
|
The Directors consider that tax will be payable at varying rates according to the country of incorporation of its subsidiary undertakings and have provided on that basis.
The tax charge for the six months ended 30 September 2026 has been calculated by applying the effective tax rate which is expected to apply to the Group for the year ending 31 March 2027, using rates substantially enacted by 30 September 2026.
7 Earnings per share
|
|
Unaudited |
Unaudited |
Audited |
|
|
6 months ended |
6 months ended |
Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
Earnings per share pre-exceptional items attributable to the ordinary equity holders of the Company: |
|
|
|
|
Basic (loss)/earnings per share |
1.03p |
(6.10)p |
(3.45)p |
|
Diluted (loss)/earnings per share |
1.02p |
(6.10)p |
(3.45)p |
|
Earnings per share from total operations attributable to the ordinary equity holders of the Company: |
|
|
|
|
Basic earnings /(loss) per share |
1.03p |
11.57p |
(0.33)p |
|
Diluted earnings /(loss) per share |
1.02p |
11.54p |
(0.33)p |
The calculation of basic and diluted earnings per share is based on the profit attributable to ordinary shareholders divided by the weighted average number of shares in issue during the year, as explained below:
|
|
Ordinary 5p shares |
|
|
|
Weighted |
|
|
|
average |
Diluted |
|
|
number |
number |
|
Six months ended 30 September 2026 |
16,659,004 |
16,700,994 |
|
Six months ended 30 September 2025 |
15,931,609 |
15,961,715 |
|
Year ended 31 March 2026 |
16,267,526 |
16,299,731 |
8 Cash, cash equivalents and short-term deposits
|
|
Unaudited |
Unaudited |
Audited |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Cash on deposit |
– |
3,531 |
– |
|
Cash at bank |
5,366 |
5,249 |
6,255 |
|
|
5,366 |
8,780 |
6,255 |
|
Short-term cash deposits |
5,582 |
1,901 |
6,545 |
|
|
10,948 |
10,681 |
12,800 |
9 Adjusted EBITDA
Adjusted earnings before interest, tax, depreciation and amortisation (‘Adjusted EBITDA') is defined as profit before taxation and before all interest, tax, depreciation and amortisation charges, exceptional items and before share-based payments. The following is a reconciliation of the Adjusted EBITDA for the three periods presented:
|
|
Unaudited |
Unaudited |
Audited |
|
|
6 months ended |
6 months ended |
Year ended |
|
|
30/09/26 |
30/09/25 |
31/03/26 |
|
|
£’000 |
£’000 |
£’000 |
|
Profit/(loss) before taxation (earnings) |
259 |
2,516 |
(74) |
|
Adjustments for: |
|
|
|
|
Finance income |
(109) |
(122) |
(226) |
|
Finance expense |
39 |
50 |
91 |
|
Depreciation |
311 |
322 |
581 |
|
Depreciation – right-of-use assets |
214 |
217 |
435 |
|
Amortisation of development costs |
1,098 |
1,263 |
2,529 |
|
Amortisation of other intangibles |
183 |
218 |
409 |
|
Share-based payments |
126 |
145 |
288 |
|
Impairment of development costs |
– |
– |
4,186 |
|
Profit on disposal of fixed assets |
– |
(3,406) |
(5,876) |
|
Adjusted EBITDA |
2,121 |
1,203 |
2,343 |
10 General
Other than already stated within the Chief Executive’s Review, there have been no important events during the first six months of the financial year that have impacted this Half Yearly Report.
There have been no related party transactions or changes in related party transactions described in the latest Annual Report that could have a material effect on the financial position or performance of the Group in the first six months of the financial year.
The auditor’s report on those accounts did not contain a statement under Section 498(2) or (3) of the Companies Act 2006. This Half Yearly Report has not been audited by the Group auditor.
A copy of this Half Yearly Report can be viewed on the Company website: www.cmlmicroplc.com.
11 Approvals
The Directors approved this Half Yearly Report on 17 November 2026.